Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/american-medical-association/connections-between-clonal-hematopoiesis-cardiovascular-disease-and-Ff0m8ptvlk
References (71)
-
Joanne Hsu, Joanne Hsu, Tajhal Dayaram, A. Tovy, E. Braekeleer, M. Jeong, Feng Wang, Jianhua Zhang, T. Heffernan, S. Gera, Jeffrey Kovacs, J. Marszalek, C. Bristow, Yuanqing Yan, G. Garcia-Manero, H. Kantarjian, G. Vassiliou, P. Futreal, L. Donehower, Koichi Takahashi, M. Goodell, M. Goodell (2018)
PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyCell Stem Cell, 23
-
Catherine Coombs, A. Zehir, S. Devlin, A. Kishtagari, Aijazuddin Syed, P. Jonsson, D. Hyman, D. Solit, M. Robson, J. Baselga, M. Arcila, M. Ladanyi, M. Tallman, R. Levine, M. Berger (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.Cell stem cell, 21 3
-
A. Pandey, S. Garg, Monica Khunger, D. Darden, C. Ayers, D. Kumbhani, Helen Mayo, J. Lemos, J. Berry (2015)
Dose–Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-AnalysisCirculation, 132
-
E. Papaemmanuil, M. Gerstung, L. Malcovati, S. Tauro, G. Gundem, P. Loo, Christopher Yoon, Peter Ellis, D. Wedge, A. Pellagatti, A. Shlien, M. Groves, S. Forbes, K. Raine, Jonathon Hinton, L. Mudie, Stuart Mclaren, Claire Hardy, Calli Latimer, M. Porta, S. O'meara, Ilaria Ambaglio, A. Gallì, A. Butler, G. Walldin, J. Teague, L. Quek, A. Sternberg, C. Gambacorti-Passerini, N. Cross, A. Green, J. Boultwood, P. Vyas, E. Hellstrom-Lindberg, D. Bowen, M. Cazzola, M. Stratton, P. Campbell (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes.Blood, 122 22
-
J. Kahn, P. Miller, A. Silver, R. Sellar, Shruti Bhatt, C. Gibson, M. McConkey, Dylan Adams, B. Mar, Philipp Mertins, Shaunt Fereshetian, Karsten Krug, Haoling Zhu, A. Letai, S. Carr, J. Doench, S. Jaiswal, B. Ebert (2018)
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells.Blood, 132 11
-
K. Bolton, N. Gillis, Catherine Coombs, Koichi Takahashi, A. Zehir, R. Bejar, G. Garcia-Manero, A. Futreal, B. Jensen, L. Diaz, Dipti Gupta, S. Mantha, V. Klimek, E. Papaemmanuil, R. Levine, E. Padron (2019)
Managing Clonal Hematopoiesis in Patients With Solid Tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37 1
-
J. Sundbøll, K. Veres, E. Horváth-Puhó, K. Adelborg, H. Sørensen (2018)
Risk and Prognosis of Cancer After Lower Limb Arterial ThrombosisCirculation, 138
-
T. Hasin, Y. Gerber, S. Weston, Ruoxiang Jiang, J. Killian, S. Manemann, J. Cerhan, V. Roger (2014)
Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.Journal of the American College of Cardiology, 68 3
-
L. Shlush, Sasan Zandi, Amanda Mitchell, W. Chen, J. Brandwein, Vikas Gupta, J. Kennedy, A. Schimmer, A. Schuh, K. Yee, Jessica Mcleod, M. Doedens, Jessie Medeiros, René Marke, Hyeoung-Joon Kim, Kwon Lee, J. McPherson, T. Hudson, Andrew Brown, Quang Trinh, Lincoln Stein, M. Minden, Jean Wang, J. Dick (2014)
Identification of pre-leukemic hematopoietic stem cells in acute leukemiaNature, 506
-
H. Abdel-Qadir, P. Austin, Douglas Lee, E. Amir, J. Tu, P. Thavendiranathan, K. Fung, G. Anderson (2017)
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast CancerJAMA Cardiology, 2
-
Florian Zink, S. Stacey, G. Norddahl, M. Frigge, O. Magnusson, I. Jónsdóttir, T. Thorgeirsson, A. Sigurdsson, S. Gudjonsson, J. Gudmundsson, J. Jónasson, L. Tryggvadottir, T. Jónsson, A. Helgason, Arnaldur Gylfason, P. Sulem, T. Rafnar, U. Thorsteinsdóttir, D. Gudbjartsson, G. Másson, A. Kong, K. Stefánsson (2017)
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.Blood, 130 6
-
M. Buscarlet, S. Provost, Y. Zada, A. Barhdadi, Vincent Bourgoin, G. Lépine, L. Mollica, N. Szuber, M. Dubé, L. Busque (2017)
DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions.Blood, 130 6
-
R. Lindsley, B. Mar, E. Mazzola, Peter Grauman, S. Shareef, Steven Allen, A. Pigneux, M. Wetzler, Robert Stuart, H. Erba, Lloyd Damon, B. Powell, Neal Lindeman, D. Steensma, M. Wadleigh, D. DeAngelo, D. Neuberg, Richard Stone, Benjamin Ebert (2015)
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.Blood, 125 9
-
D. Steensma (2018)
Clinical consequences of clonal hematopoiesis of indeterminate potential.Hematology. American Society of Hematology. Education Program, 2018 1
-
J. Fuster, Susan MacLauchlan, M. Zuriaga, Maya Polackal, Allison Ostriker, Raja Chakraborty, Chia-Ling Wu, S. Sano, S. Muralidharan, C. Rius, Jacqueline Vuong, S. Jacob, Varsha Muralidhar, A. Robertson, M. Cooper, V. Andrés, K. Hirschi, K. Martin, K. Walsh (2017)
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in miceScience, 355
-
O. Guryanova, K. Shank, B. Spitzer, Luisa Luciani, R. Koche, Francine Garrett-Bakelman, C. Ganzel, B. Durham, A. Mohanty, G. Hoermann, S. Rivera, Alan Chramiec, E. Pronier, Lennart Bastian, M. Keller, D. Tovbin, Evangelia Loizou, Abby Weinstein, Adriana Gonzalez, Y. Lieu, J. Rowe, F. Pastore, A. McKenney, A. Krivtsov, W. Sperr, J. Cross, C. Mason, M. Tallman, M. Arcila, O. Abdel-Wahab, S. Armstrong, S. Kubicek, P. Staber, M. Gönen, E. Paietta, A. Melnick, S. Nimer, S. Mukherjee, R. Levine (2016)
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingNature Medicine, 22
-
C. Gibson, R. Lindsley, V. Tchekmedyian, B. Mar, Jiantao Shi, S. Jaiswal, A. Bosworth, L. Francisco, Jianbo He, A. Bansal, E. Morgan, A. LaCasce, A. Freedman, D. Fisher, E. Jacobsen, P. Armand, E. Alyea, J. Koreth, V. Ho, R. Soiffer, J. Antin, J. Ritz, S. Nikiforow, S. Forman, F. Michor, D. Neuberg, R. Bhatia, S. Bhatia, B. Ebert (2017)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 14
-
Ting-ting Li, Shaozhong Wei, Yun Shi, Shuo Pang, Q. Qin, Jieyun Yin, Yunte Deng, Qiongrong Chen, S. Wei, S. Nie, Li Liu (2015)
The dose–response effect of physical activity on cancer mortality: findings from 71 prospective cohort studiesBritish Journal of Sports Medicine, 50
-
L. Shlush, Sasan Zandi, S. Itzkovitz, A. Schuh (2015)
Aging, clonal hematopoiesis and preleukemia: not just bad luck?International Journal of Hematology, 102
-
P. Thavendiranathan, H. Abdel-Qadir, H. Fischer, X. Camacho, E. Amir, P. Austin, Douglas Lee (2016)
Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based Cohort Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 34 19
-
F. Paneni, Candela Cañestro, P. Libby, T. Lüscher, G. Camici (2017)
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels.Journal of the American College of Cardiology, 69 15
-
P. Thavendiranathan, M. Nolan (2016)
An emerging epidemic: cancer and heart failure.Clinical science, 131 2
-
Qian Zhang, K. Zhao, Qicong Shen, Yanmei Han, Yan Gu, Xia Li, Dezhi Zhao, Yiqi Liu, Chunmei Wang, Xiang Zhang, X. Su, Juan Liu, W. Ge, R. Levine, Nan Li, Xuetao Cao (2015)
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6Nature, 525
-
TaeHyung Kim, Marc Tyndel, Hyeoung-Joon Kim, Jae-Sook Ahn, S. Choi, H. Park, Yeo-Kyeoung Kim, Soo Kim, J. Lipton, Zhaolei Zhang, Dennis Kim (2017)
Spectrum of somatic mutation dynamics in chronic myeloid leukemia following tyrosine kinase inhibitor therapy.Blood, 129 1
-
E. Shumilov, J. Flach, T. Pabst, M. Fiedler, A. Angelillo-Scherrer, L. Trümper, R. Joncourt, A. Kohlmann, U. Bacher (2018)
Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.Critical reviews in oncology/hematology, 126
-
Natarajan (2018)
Clonal hematopoiesis: somatic mutations in blood cells and atherosclerosis.Circ Genom Precis Med, 11
-
Terrence Wong, Christopher Miller, Matthew Jotte, N. Bagegni, J. Baty, A. Schmidt, A. Cashen, E. Duncavage, Nichole Helton, M. Fiala, R. Fulton, S. Heath, M. Janke, K. Luber, P. Westervelt, R. Vij, J. Dipersio, J. Welch, T. Graubert, M. Walter, T. Ley, D. Link (2018)
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialNature Communications, 9
-
Sagi Abelson, G. Collord, Stanley Ng, O. Weissbrod, N. Cohen, E. Niemeyer, Noam Barda, P. Zuzarte, Lawrence Heisler, Y. Sundaravadanam, R. Luben, S. Hayat, Ting Wang, Zhen Zhao, I. Cirlan, T. Pugh, David Soave, Karen Ng, Calli Latimer, Claire Hardy, K. Raine, David Jones, Diana Hoult, Abigail Britten, J. McPherson, M. Johansson, Faridah Mbabaali, Jenna Eagles, Jessica Miller, Daniel Pasternack, Lee Timms, P. Krzyzanowski, P. Awadalla, Rui Costa, E. Segal, S. Bratman, P. Beer, S. Behjati, I. Martincorena, Jean Wang, K. Bowles, J. Quirós, A. Karakatsani, C. Vecchia, A. Trichopoulou, E. Salamanca-Fernández, J. Huerta, A. Barricarte, R. Travis, R. Tumino, G. Masala, H. Boeing, S. Panico, R. Kaaks, A. Krämer, S. Sieri, E. Riboli, P. Vineis, M. Foll, J. Mckay, S. Polidoro, N. Sala, K. Khaw, R. Vermeulen, P. Campbell, E. Papaemmanuil, M. Minden, A. Tanay, R. Balicer, N. Wareham, M. Gerstung, J. Dick, P. Brennan, G. Vassiliou, L. Shlush (2018)
Prediction of acute myeloid leukaemia risk in healthy individualsNature, 559
-
S. Jaiswal, P. Fontanillas, J. Flannick, A. Manning, Peter Grauman, B. Mar, R. Lindsley, C. Mermel, N. Burtt, A. Chavez, J. Higgins, V. Moltchanov, F. Kuo, M. Kluk, B. Henderson, L. Kinnunen, H. Koistinen, C. Ladenvall, G. Getz, A. Correa, B. Banahan, S. Gabriel, S. Kathiresan, H. Stringham, M. McCarthy, M. Boehnke, J. Tuomilehto, C. Haiman, L. Groop, G. Atzmon, James Wilson, D. Neuberg, D. Altshuler, B. Ebert (2014)
Age-related clonal hematopoiesis associated with adverse outcomes.The New England journal of medicine, 371 26
-
L. Malcovati, A. Gallì, E. Travaglino, Ilaria Ambaglio, E. Rizzo, E. Molteni, C. Elena, V. Ferretti, S. Catricalà, E. Bono, G. Todisco, Antonio Bianchessi, E. Rumi, S. Zibellini, D. Pietra, E. Boveri, C. Camaschella, D. Toniolo, E. Papaemmanuil, S. Ogawa, M. Cazzola (2017)
Clinical significance of somatic mutation in unexplained blood cytopenia.Blood, 129 25
-
J. Simes, K. Robledo, H. White, D. Espinoza, R. Stewart, D. Sullivan, T. Zeller, W. Hague, P. Nestel, P. Glasziou, A. Keech, J. Elliott, S. Blankenberg, A. Tonkin (2018)
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID StudyCirculation, 138
-
Steensma (2018)
Clinical consequences of clonal hematopoiesis of indeterminate potential.Blood Adv, 2
-
P. Natarajan, S. Jaiswal, S. Kathiresan (2018)
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and AtherosclerosisCirculation: Genomic and Precision Medicine, 11
-
J. Douxfils, Hélène Haguet, F. Mullier, C. Chatelain, C. Graux, J. Dogné (2016)
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival: A Systematic Review and Meta-analysis.JAMA oncology, 2 5
-
T. Yoshizato, B. Dumitriu, K. Hosokawa, H. Makishima, Kenichi Yoshida, D. Townsley, A. Sato-Otsubo, Yusuke Sato, Delong Liu, Hiromichi Suzuki, Colin Wu, Y. Shiraishi, M. Clemente, K. Kataoka, Y. Shiozawa, Y. Okuno, K. Chiba, Hiroko Tanaka, Y. Nagata, T. Katagiri, A. Kon, M. Sanada, P. Scheinberg, S. Miyano, J. Maciejewski, S. Nakao, N. Young, S. Ogawa (2015)
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.The New England journal of medicine, 373 1
-
G. Genovese, A. Kähler, R. Handsaker, J. Lindberg, S. Rose, S. Bakhoum, K. Chambert, E. Mick, B. Neale, M. Fromer, S. Purcell, Oscar Svantesson, M. Landén, M. Höglund, S. Lehmann, S. Gabriel, J. Moran, E. Lander, P. Sullivan, P. Sklar, H. Grönberg, C. Hultman, S. Mccarroll (2014)
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.The New England journal of medicine, 371 26
-
J. Fuster, K. Walsh (2018)
Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular DiseaseCirculation Research, 122
-
Xie (2014)
Age-related mutations associated with clonal hematopoietic expansion and malignancies.Nat Med, 20
-
D. Steensma, R. Bejar, S. Jaiswal, R. Lindsley, M. Sekeres, R. Hasserjian, B. Ebert (2015)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.Blood, 126 1
-
S. Jaiswal, P. Natarajan, A. Silver, C. Gibson, A. Bick, E. Shvartz, M. McConkey, N. Gupta, S. Gabriel, D. Ardissino, U. Baber, R. Mehran, V. Fuster, J. Danesh, P. Frossard, D. Saleheen, O. Melander, G. Sukhova, D. Neuberg, P. Libby, S. Kathiresan, B. Ebert (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseThe New England Journal of Medicine, 377
-
Lena Dorsheimer, B. Assmus, T. Rasper, Christina Ortmann, A. Ecke, K. Abou-El-Ardat, T. Schmid, B. Brüne, Sebastian Wagner, H. Serve, Jedrzej Hoffmann, F. Seeger, S. Dimmeler, A. Zeiher, M. Rieger (2018)
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart FailureJAMA Cardiology, 4
-
A. Sperling, C. Gibson, B. Ebert (2016)
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemiaNature Reviews Cancer, 17
-
Rona Reibis, A. Treszl, Karl Wegscheider, Kurt Bestehorn, B. Karmann, Heinz Völler
Vascular Health and Risk Management -
C. Gibson, D. Steensma (2018)
New Insights from Studies of Clonal HematopoiesisClinical Cancer Research, 24
-
Terrence Wong, G. Ramsingh, A. Young, Christopher Miller, Waseem Touma, J. Welch, T. Lamprecht, D. Shen, J. Hundal, R. Fulton, S. Heath, J. Baty, J. Klco, L. Ding, E. Mardis, P. Westervelt, J. Dipersio, M. Walter, T. Graubert, T. Ley, T. Druley, D. Link, R. Wilson (2014)
The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AMLNature, 518
-
D. Saleheen, M. Zaidi, A. Rasheed, U. Ahmad, A. Hakeem, M. Murtaza, Waleed Kayani, A. Faruqui, A. Kundi, K. Zaman, Zia Yaqoob, Liaquat Cheema, A. Samad, S. Rasheed, N. Mallick, M. Azhar, R. Jooma, A. Gardezi, N. Memon, Abdul Ghaffar, Fazal-ur-Rehman, Nadir Khan, N. Shah, A. Shah, M. Samuel, F. Hanif, Madiha Yameen, Sobia Naz, A. Sultana, Aisha Nazir, Shehzad Raza, M. Shazad, S. Nasim, M. Javed, S. Ali, Mehmood Jafree, M. Nisar, M. Daood, Altaf Hussain, N. Sarwar, A. Kamal, P. Deloukas, M. Ishaq, P. Frossard, J. Danesh (2009)
The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South AsiaEuropean Journal of Epidemiology, 24
-
C. Lindsley, W. Saber, B. Mar, R. Redd, Tao Wang, M. Haagenson, Peter Grauman, Zhen-Huan Hu, S. Spellman, Stephanie Lee, M. Verneris, K. Hsu, K. Fleischhauer, C. Cutler, J. Antin, D. Neuberg, B. Ebert (2017)
Prognostic Mutations in Myelodysplastic Syndrome after Stem‐Cell TransplantationThe New England Journal of Medicine, 376
-
A. Khera, C. Emdin, Isabel Drake, P. Natarajan, A. Bick, N. Cook, D. Chasman, U. Baber, R. Mehran, D. Rader, V. Fuster, E. Boerwinkle, O. Melander, M. Orho-Melander, P. Ridker, S. Kathiresan (2016)
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease.The New England journal of medicine, 375 24
-
A. Young, G. Challen, B. Birmann, T. Druley (2016)
Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adultsNature Communications, 7
-
A. Bonnefond, Boris Skrobek, S. Lobbens, Elodie Eury, Dorothée Thuillier, S. Cauchi, O. Lantieri, B. Balkau, E. Riboli, M. Marre, G. Charpentier, L. Yengo, P. Froguel (2013)
Association between large detectable clonal mosaicism and type 2 diabetes with vascular complicationsNature Genetics, 45
-
S. Sano, Kosei Oshima, Ying Wang, Susan MacLauchlan, Y. Katanasaka, Miho Sano, M. Zuriaga, M. Yoshiyama, D. Goukassian, M. Cooper, J. Fuster, K. Walsh (2018)
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.Journal of the American College of Cardiology, 71 8
-
A. Sehgal, P. Gimotty, Jianhua Zhao, Jingmei Hsu, R. Daber, J. Morrissette, S. Luger, A. Loren, M. Carroll (2015)
DNMT3A Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous LeukemiaClinical Cancer Research, 21
-
S. Sano, Kosei Oshima, Ying Wang, Y. Katanasaka, Miho Sano, K. Walsh (2018)
CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular DiseaseCirculation Research, 123
-
E. Swisher, M. Harrell, B. Norquist, T. Walsh, M. Brady, Ming Lee, R. Hershberg, K. Kalli, H. Lankes, Eric Konnick, C. Pritchard, B. Monk, J. Chan, R. Burger, S. Kaufmann, M. Birrer (2016)
Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.JAMA oncology, 2 3
-
Pinkal Desai, N. Mencia-Trinchant, O. Savenkov, M. Simon, Gloria Cheang, Sangmin Lee, Michael Samuel, E. Ritchie, M. Guzman, K. Ballman, G. Roboz, D. Hassane (2018)
Somatic mutations precede acute myeloid leukemia years before diagnosisNature Medicine, 24
-
Koichi Takahashi, Koichi Takahashi, Feng Wang, H. Kantarjian, Denaha Doss, Kanhav Khanna, Erika Thompson, Li Zhao, K. Patel, S. Neelapu, C. Gumbs, C. Bueso-Ramos, C. Dinardo, S. Colla, F. Ravandi, Jianhua Zhang, Xuelin Huang, Xifeng Wu, F. Samaniego, G. Garcia-Manero, P. Futreal (2016)
Pre-leukemic clonal hematopoiesis and the risk of therapy-related myeloid neoplasms: a case-control studyThe Lancet. Oncology, 18
-
R. Ptashkin, D. Mandelker, Catherine Coombs, K. Bolton, Zarina Yelskaya, D. Hyman, D. Solit, J. Baselga, M. Arcila, M. Ladanyi, Liying Zhang, R. Levine, M. Berger, A. Zehir (2018)
Prevalence of Clonal Hematopoiesis Mutations in Tumor-Only Clinical Genomic Profiling of Solid TumorsJAMA Oncology, 4
-
N. Gillis, M. Ball, Qing Zhang, Zhenjun Ma, Yulong Zhao, S. Yoder, M. Balasis, Tania Mesa, D. Sallman, J. Lancet, R. Komrokji, A. List, H. McLeod, M. Alsina, R. Baz, K. Shain, D. Rollison, E. Padron (2017)
Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.The Lancet. Oncology, 18 1
-
S. Armenian, C. Lacchetti, A. Barac, J. Carver, L. Constine, N. Denduluri, S. Dent, P. Douglas, J. Durand, M. Ewer, C. Fabian, M. Hudson, M. Jessup, Lee Jones, B. Ky, E. Mayer, J. Moslehi, K. Oeffinger, Katharine Ray, K. Ruddy, D. Lenihan (2017)
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 8
-
Yuebi Hu, B. Ulrich, Julianna Supplee, Y. Kuang, Patrick Lizotte, N. Feeney, N. Guibert, M. Awad, Kwok-kin Wong, P. Jänne, C. Paweletz, G. Oxnard (2018)
False-Positive Plasma Genotyping Due to Clonal HematopoiesisClinical Cancer Research, 24
-
L. Shlush (2018)
Age-related clonal hematopoiesis.Blood, 131 5
-
R. Acuna-Hidalgo, Hilal Sengul, M. Steehouwer, M. Vorst, S. Vermeulen, L. Kiemeney, J. Veltman, C. Gilissen, A. Hoischen (2017)
Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life.American journal of human genetics, 101 1
-
Aghel (2017)
Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance.Vasc Health Risk Manag, 13
-
Wouter Meijers, M. Maglione, S. Bakker, R. Oberhuber, Lyanne Kieneker, S. Jong, B. Haubner, W. Nagengast, A. Lyon, B. Vegt, D. Veldhuisen, B. Westenbrink, P. Meer, H. Silljé, R. Boer (2018)
Heart Failure Stimulates Tumor Growth by Circulating FactorsCirculation, 138
-
P. Ridker, B. Everett, T. Thuren, J. Macfadyen, W. Chang, C. Ballantyne, F. Fonseca, J. Nicolau, W. Koenig, S. Anker, J. Kastelein, J. Cornel, P. Pais, D. Pella, J. Genest, R. Cífková, A. Lorenzatti, T. Forster, Z. Kobalava, L. Vida-Simiti, M. Flather, H. Shimokawa, H. Ogawa, M. Dellborg, Paulo Rossi, R. Troquay, P. Libby, R. Glynn (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic DiseaseThe New England Journal of Medicine, 377
-
Wong (2015)
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.Nature, 518
-
P. Ridker, J. Macfadyen, T. Thuren, B. Everett, P. Libby, R. Glynn, P. Ridker, A. Lorenzatti, H. Krum, J. Varigos, P. Siostrzonek, P. Sinnaeve, F. Fonseca, J. Nicolau, N. Gotcheva, J. Genest, Huo Yong, M. Urina-Triana, D. Miličić, R. Cífková, R. Vettus, W. Koenig, S. Anker, A. Manolis, F. Wyss, T. Forster, A. Sigurdsson, P. Pais, A. Fucili, H. Ogawa, H. Shimokawa, I. Veze, B. Petrauskiene, Leon Salvador, J. Kastelein, J. Cornel, T. Klemsdal, F. Medina, A. Budaj, L. Vida-Simiti, Z. Kobalava, P. Otasevic, D. Pella, M. Lainščak, K. Seung, P. Commerford, M. Dellborg, M. Donath, Juey-Jen Hwang, H. Kultursay, M. Flather, C. Ballantyne, S. Bilazarian, William Chang, C. East, B. Everett, L. Forgosh, Robert Glynn, Barry Harris, M. Ligueros, E. Bohula, Bindu Charmarthi, Susan Cheng, S. Chou, J. Danik, G. McMahon, B. Maron, M. Ning, B. Olenchock, Reena Pande, T. Perlstein, A. Pradhan, N. Rost, A. Singhal, V. Taqueti, N. Wei, H. Burris, A. Cioffi, A. Dalseg, N. Ghosh, J. Gralow, T. Mayer, H. Rugo, V. Fowler, A. Limaye, S. Cosgrove, D. Levine, Renato Lopes, J. Scott, R. Hilkert, Georgia Tamesby, C. Mickel, B. Manning, Julian Woelcke, M. Tan, S. Manfreda, Tom Ponce, J. Kam, R. Saini, Kehur Banker, T. Salko, Panjat Nandy, Ronda Tawfik, Greg O'Neil, S. Manne, Pravin Jirvankar, S. Lal, Deepak Nema, Jaison Jose, R. Collins, K. Bailey, R. Blumenthal, H. Colhoun, B. Gersh (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trialThe Lancet, 390
-
J. Weitzel, E. Chao, Bita Nehoray, Lily Tongeren, H. LaDuca, K. Blazer, T. Slavin, T. Pesaran, Christina Rybak, Ilana Solomon, Mariana Niell-Swiller, Jill Dolinsky, D. Castillo, A. Elliott, C. Gau, V. Speare, K. Jasperson (2017)
Somatic TP53 variants frequently confound germline testing resultsGenetics in medicine : official journal of the American College of Medical Genetics, 20
-
M. Kristiansen, G. Knudsen, L. Bathum, A. Naumova, T. Sørensen, T. Brix, A. Svendsen, K. Christensen, K. Kyvik, K. Ørstavik (2005)
Twin study of genetic and aging effects on X chromosome inactivationEuropean Journal of Human Genetics, 13
-
Mingchao Xie, Charles Lu, Jiayin Wang, M. McLellan, Kimberly Johnson, M. Wendl, Joshua McMichael, Heather Schmidt, V. Yellapantula, Christopher Miller, B. Ozenberger, J. Welch, D. Link, M. Walter, E. Mardis, J. Dipersio, Feng Chen, R. Wilson, T. Ley, L. Ding (2014)
Age-related cancer mutations associated with clonal hematopoietic expansionNature medicine, 20
-
P. Thavendiranathan, H. Abdel-Qadir, H. Fischer, Y. Liu, X. Camacho, E. Amir, P. Austin, Douglas Lee (2018)
Risk-Imaging Mismatch in Cardiac Imaging Practices for Women Receiving Systemic Therapy for Early-Stage Breast Cancer: A Population-Based Cohort Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36 30
- Publisher
- American Medical Association
- Copyright
- Copyright 2019 American Medical Association. All Rights Reserved.
- ISSN
- 2380-6583
- eISSN
- 2380-6591
- DOI
- 10.1001/jamacardio.2019.0302
- Publisher site
- See Article on Publisher Site
Abstract
This narrative review discusses the evidence for clonal hematopoiesis as a physiological factor connecting cancer and cardiovascular disease.
Journal
JAMA Cardiology – American Medical Association
Published: Apr 13, 2019